GenoSensor

GenoSensor is a private U.S. genomic technology company based in Tempe, Arizona that develops and markets products and services for genomic research, molecular biology, and clinical diagnostic applications. Its offerings include microRNA microarrays, qRT-PCR kits, DNA extraction kits, bioassay services, and a SARS-CoV-2 RT-PCR diagnostic kit that received FDA Emergency Use Authorization in 2020. The company positions itself as a provider of end-to-end gene profiling and screening solutions, including sample-in/data-out services for gene expression profiling, genotyping, sequencing, and related genomic workflows. GenoSensor also sells educational molecular biology products and appears to commercialize certain clinical applications through partners such as Clinicogen. Overall, it is best characterized as a small commercial genomics tools and assay company rather than a therapeutics developer.